Search Contract Opportunities

Study of E-Cigarette Aerosol Toxicity in In Vivo Nonclinical Models.

ID: FDA-19-SOL-1207956 • Type: Synopsis Solicitation
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: Aug. 27, 2019, 4:04 p.m. EDT
The purpose of this amendment is to provide answers to questions received. Please refer to attached document "1207956-Q&A.pdf" Clarification/Amendment: "FDA-19-SOL-1207956.pdf"(Section 5.3/pg. 40)- Quotes shall be due September 3rd, 2019 3:00PM Eastern Time; Not August 26th, 2019 3:00PM Eastern Time as listed.
Posted: Aug. 21, 2019, 10:54 a.m. EDT

The U.S. Food and Drug Administration (FDA)'s Center for Tobacco Products (CTP) has a requirement for evaluating e-cigarette aerosols in in vivo nonclinical models.

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a separate written solicitation will not be issued.

This solicitation is a Request for Quote (RFQ) using FAR Parts 12 and 15 procedures. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2019-05. The North American Industry Classification System (NAICS) code for the proposed acquisition is 541380, Testing Laboratories.

All quotes submitted in response to this solicitation shall be to via- e-mail to the contract specialist at Christopher.McGucken@fda.hhs.gov no later than August 26th 2019 3:00PM Eastern Time.

All questions in response to this solicitation shall be submitted no later than September 3rd, 2019 3:00PM Eastern Time.

Please refer to attached document "FDA-19-SOL-1207956.pdf" for full description/details.


Show All

Overview

Agency
Food and Drug Administration (FDA) [HHS]
Response Deadline
Sept. 3, 2019, 4:00 p.m. EDT Past Due
Posted
Aug. 21, 2019, 10:54 a.m. EDT (updated: Aug. 27, 2019, 4:04 p.m. EDT)
Set Aside
None
NAICS
541380 - Testing Laboratories and Services
PSC
B - Special Studies/Analysis, Not R&D
Place of Performance
Not Provided
Source
SAM
Current SBA Size Standard
$19 Million
Est. Level of Competition
Low
On 8/21/19 Food and Drug Administration issued Synopsis Solicitation FDA-19-SOL-1207956 for Study of E-Cigarette Aerosol Toxicity in In Vivo Nonclinical Models. due 9/3/19. The opportunity was issued full & open with NAICS 541380 and PSC B.
Primary Contact
Title
Contract Specialist
Name
Christopher R. McGucken   Profile
Email
christopher.mcgucken@fda.hhs.gov
Phone
(240) 402-7566

Documents

Posted documents for Synopsis Solicitation FDA-19-SOL-1207956

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Contract Awards

Prime contracts awarded through Synopsis Solicitation FDA-19-SOL-1207956

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Synopsis Solicitation FDA-19-SOL-1207956

Similar Active Opportunities

Open contract opportunities similar to Synopsis Solicitation FDA-19-SOL-1207956

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > Office of Acquisitions and Grants Services - Rockville
Source Organization Code
d7d1f63fbc3d01cfc95f2104d02e88c0
Last Updated
Sept. 18, 2019
Last Updated By
PI33_DR_IAE_51681
Archive Date
Sept. 18, 2019